| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |